These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 26730885)

  • 1. Developing New Immunosuppression for the Next Generation of Transplant Recipients: The Path Forward.
    Stegall MD; Morris RE; Alloway RR; Mannon RB
    Am J Transplant; 2016 Apr; 16(4):1094-101. PubMed ID: 26730885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-center experience with nirmatrelvir/ritonavir in kidney transplant recipients on tacrolimus maintenance immunosuppression.
    Mecadon K; Arvanitis P; Farmakiotis D; Rogers R
    Clin Transplant; 2022 Aug; 36(8):e14752. PubMed ID: 35713302
    [No Abstract]   [Full Text] [Related]  

  • 3. Graft rejection after immune checkpoint inhibitor therapy in solid organ transplant recipients.
    Smedman TM; Line PD; Guren TK; Dueland S
    Acta Oncol; 2018 Oct; 57(10):1414-1418. PubMed ID: 29912605
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunosuppression in uterus transplantation: from transplant to delivery.
    D'Amico G; Del Prete L; Eghtesad B; Hashimoto K; Miller C; Tzakis A; Quintini C; Falcone T
    Expert Opin Pharmacother; 2023 Jan; 24(1):29-35. PubMed ID: 35723045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunosuppression in solid organ-transplant recipients and impact on nutrition support.
    Wilson NK; Kataria AD
    Nutr Clin Pract; 2024 Feb; 39(1):109-116. PubMed ID: 38030572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimization of de novo belatacept-based immunosuppression administered to renal transplant recipients.
    Kirk AD; Adams AB; Durrbach A; Ford ML; Hildeman DA; Larsen CP; Vincenti F; Wojciechowski D; Woodle ES
    Am J Transplant; 2021 May; 21(5):1691-1698. PubMed ID: 33128812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Public-private partnerships in transplant drug development.
    Albrecht R; Papadopoulos EJ; Campbell M; Daniels S; Kluetz PG; Parekh A; Wang Y
    Am J Transplant; 2020 Feb; 20(2):377-381. PubMed ID: 31553120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. We Asked the Experts: Toward Personalized Immunosuppression for Liver Transplant Recipients.
    Lew J; Perito ER; Feng S
    World J Surg; 2022 Apr; 46(4):876-877. PubMed ID: 35037069
    [No Abstract]   [Full Text] [Related]  

  • 9. Longitudinal immunosuppression data can minimize misclassification bias in solid organ transplantation cohorts.
    Laaksonen MA; Webster AC; McCaughan GW; Keogh AM; Grulich AE; Vajdic CM
    Clin Transplant; 2019 Feb; 33(2):e13470. PubMed ID: 30586213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abatacept as rescue immunosuppression after calcineurin inhibitor treatment failure in renal transplantation.
    Badell IR; Karadkhele GM; Vasanth P; Farris AB; Robertson JM; Larsen CP
    Am J Transplant; 2019 Aug; 19(8):2342-2349. PubMed ID: 30768841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meeting report: FDA public meeting on patient-focused drug development and medication adherence in solid organ transplant patients.
    Ettenger R; Albrecht R; Alloway R; Belen O; Cavaillé-Coll MW; Chisholm-Burns MA; Dew MA; Fitzsimmons WE; Nickerson P; Thompson G; Vaidya P
    Am J Transplant; 2018 Mar; 18(3):564-573. PubMed ID: 29288623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Posttransplant biopsy risk for stable long-term pediatric liver transplant recipients: 451 percutaneous biopsies from two multicenter immunosuppression withdrawal trials.
    Perito ER; Martinez M; Turmelle YP; Mason K; Spain KM; Bucuvalas JC; Feng S
    Am J Transplant; 2019 May; 19(5):1545-1551. PubMed ID: 30614623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunosuppression in HIV-Positive Heart Transplant Recipients During the Post-COVID-19 Era.
    Mahrokhian SH; Nordan T; Kawabori M
    Ann Thorac Surg; 2022 Aug; 114(2):607-608. PubMed ID: 34310920
    [No Abstract]   [Full Text] [Related]  

  • 14. Cytokine-targeted therapy for the management of solid organ transplant recipients.
    Szczepanik A; Iasella CJ; McDyer JF; Ensor CR
    Hum Immunol; 2019 Mar; 80(3):184-190. PubMed ID: 30562564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced immunosuppression improves early allograft function in a porcine kidney transplant model of donation after circulatory death.
    Xu M; Garcia-Aroz S; Banan B; Wang X; Rabe BJ; Zhou F; Nayak DK; Zhang Z; Jia J; Upadhya GA; Manning PT; Gaut JP; Lin Y; Chapman WC
    Am J Transplant; 2019 Mar; 19(3):713-723. PubMed ID: 30152136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the characteristics of adult liver transplant recipients with prope (almost) tolerance and full immunosuppression regimen.
    Shamsaeefar A; Nikoupour H; Kazemi K; Gholami S; Moosavi SA; Motazedian N; Sayadi M; Afshinnia F; Nikeghbalian S; Malekhosseini SA
    Transpl Immunol; 2021 Oct; 68():101440. PubMed ID: 34343659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction immunosuppression in kidney transplant recipients with HIV: To deplete or not to deplete?
    Agrawal A; Stosor V
    Transpl Infect Dis; 2024 Aug; 26(4):e14299. PubMed ID: 38953433
    [No Abstract]   [Full Text] [Related]  

  • 18. Longitudinal dose and type of immunosuppression in a national cohort of Australian liver, heart, and lung transplant recipients, 1984-2006.
    Na R; Laaksonen MA; Grulich AE; Webster AC; Meagher NS; McCaughan GW; Keogh AM; Vajdic CM
    Clin Transplant; 2015 Nov; 29(11):978-90. PubMed ID: 26278925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Belatacept-based immunosuppression: A calcineurin inhibitor-sparing regimen in heart transplant recipients.
    Launay M; Guitard J; Dorent R; Prevot Y; Prion F; Beaumont L; Kably B; Lecuyer L; Billaud EM; Guillemain R
    Am J Transplant; 2020 Feb; 20(2):553-563. PubMed ID: 31452337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From immunosuppression to tolerance.
    Adams DH; Sanchez-Fueyo A; Samuel D
    J Hepatol; 2015 Apr; 62(1 Suppl):S170-85. PubMed ID: 25920086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.